A lifestyle program for women with obesity and heart disease risk
Observes a lifestyle program, with or without GLP-1 medication, in women with obesity.
Plain-language title generated from the registry record
Registry title: Lifestyle Program Focused on Nourishment, Well-Being, and Health Behaviors in Women With Obesity
Key facts
- Where
- Calgary, CanadaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 35 and 75 years old?
Source: NCT07404150, who can take part
Where in Canada
- Symphony of Health ConnectionsCalgary, CanadaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Heather Conradson
- Trial code
- NCT07404150
- Record updated
- 6 April 2026
- Original description
Women, Weight and Well-Being is a 12-month research study looking at how a supportive lifestyle program may help women whose weight increases their risk for heart disease.Read full original descriptionShow less
Women, Weight, and Well-Being: An Observational Study of an Interdisciplinary Lifestyle Program With or Without GLP-1 Therapy to Support Intentional Weight Loss, Reduce Internalized Weight Bias, and Improve Positive Health Behaviors in Women With Obesity.
Women, Weight and Well-Being is a 12-month research study looking at how a supportive lifestyle program may help women whose weight increases their risk for heart disease.
The objective is to evaluate whether taking part in the program is linked with changes in: body weight and waist size; blood pressure and bloodwork related to heart health (such as cholesterol and A1C); health habits (movement, eating patterns, sleep); well-being and how women feel about their bodies, including the effects of weight stigma.
About 60 women aged 35-75 will take part. Participants will attend group sessions and have one-on-one support from a nurse, dietitian, and kinesiologist. Some participants may also use GLP-1 medication (a type of medication that can support weight loss) as part of their regular medical care, if appropriate. The study does not assign medication. Outcomes will be observed over time.
Information will be collected at the start of the program, at 6 months, and at 12 months using measurements (such as weight, waist, blood pressure), routine lab results, and questionnaires about health and well-being.
Inclusion: • Ability to provide informed consent before any study-related activities; Female; Age between 35 and 75 years; BMI ≥ 30 kg/m² with waist circumference ≥ 88 cm or BMI ≥ 27 kg/m² with obesity-related health conditions consistent with Edmonton Obesity Staging System Stage ≥ 1; Willingness to engage in a 12-month interdisciplinary lifestyle program; Ability to attend group sessions (in person or virtually) and complete follow-up visits; Alberta resident with Alberta Health Care insurance; Sufficient proficiency in English to engage with group material and communications.
Exclusion: Pregnant, breastfeeding, or planning to become pregnant during the study period; Diagnosis of type 1 diabetes; Life-limiting illness or severe medical condition where weight loss would not be clinically appropriate (e.g., advanced cancer, end-stage organ failure); clinical judgment will be used to assess suitability; Severe psychiatric illness or cognitive impairment that would interfere with participation in group sessions or study procedures; Current participation in another weight management or investigational study; Inability to comply with study procedures due to logistical, medical, or language barriers.